Terms: = Lymphoma AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
41 results:
1. Targeting the cGAS-STING Pathway Inhibits Peripheral T-cell lymphoma Progression and Enhances the Chemotherapeutic Efficacy.
Lu X; Wang S; Hua X; Chen X; Zhan M; Hu Q; Cao L; Wu Z; Zhang W; Zuo X; Gui R; Fan L; Li J; Shi W; Jin H
Adv Sci (Weinh); 2024 Mar; 11(10):e2306092. PubMed ID: 38145335
[TBL] [Abstract] [Full Text] [Related]
2. The role of cryopreservation techniques in manufacturing, transport, and storage of Car-T therapy products.
Jandova M; Stacey GN; Lanska M; Gregor I; Rozsivalova P; Bekova L; Duchacova ZW; Belada D; Radocha J; Mericka P; Fuller B
Cryo Letters; 2023; 44(3):123-133. PubMed ID: 37883165
[TBL] [Abstract] [Full Text] [Related]
3. CRISPR/Cas9-Mediated Induction of Relapse-Specific
Nguyen TTT; Tanaka Y; Sanada M; Hosaka M; Tamai M; Kagami K; Komatsu C; Somazu S; Harama D; Kasai S; Watanabe A; Akahane K; Goi K; Inukai T
Mol Pharmacol; 2023 Apr; 103(4):199-210. PubMed ID: 36669880
[TBL] [Abstract] [Full Text] [Related]
4. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacologic Inhibition of nt5c2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.
Reglero C; Dieck CL; Zask A; Forouhar F; Laurent AP; Lin WW; Albero R; Miller HI; Ma C; Gastier-Foster JM; Loh ML; Tong L; Stockwell BR; Palomero T; Ferrando AA
Cancer Discov; 2022 Nov; 12(11):2646-2665. PubMed ID: 35984649
[TBL] [Abstract] [Full Text] [Related]
6.
Giesen D; Hooge MNL; Nijland M; Heyerdahl H; Dahle J; de Vries EGE; Pool M
Sci Rep; 2022 Apr; 12(1):6286. PubMed ID: 35428777
[TBL] [Abstract] [Full Text] [Related]
7. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract] [Full Text] [Related]
8. Validation of an apoptosis assay for extracorporeal photopheresis.
Hähnel V; Dormann F; Kronenberg K; Hutchinson JA; Burkhardt R; Ahrens N
Transfus Med; 2021 Apr; 31(2):113-120. PubMed ID: 33665869
[TBL] [Abstract] [Full Text] [Related]
9. Photochemotherapy Induces Interferon Type III Expression via STING Pathway.
Biskup E; Larsen BD; Rib L; Folkersen L; Niazi O; Kamstrup MR; Sørensen CS
Cells; 2020 Nov; 9(11):. PubMed ID: 33182724
[TBL] [Abstract] [Full Text] [Related]
10. Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations.
Antić Ž; Yu J; Van Reijmersdal SV; Van Dijk A; Dekker L; Segerink WH; Sonneveld E; Fiocco M; Pieters R; Hoogerbrugge PM; Van Leeuwen FN; Van Kessel AG; Waanders E; Kuiper RP
Haematologica; 2021 Dec; 106(12):3046-3055. PubMed ID: 33147938
[TBL] [Abstract] [Full Text] [Related]
11. Effects of nt5c2 Germline Variants on 6-Mecaptopurine Metabolism in Children With Acute Lymphoblastic Leukemia.
Jiang C; Yang W; Moriyama T; Liu C; Smith C; Yang W; Qian M; Li Z; Tulstrup M; Schmiegelow K; Crews KR; Zhang H; Pui CH; Evans W; Relling M; Bhatia S; Yang JJ
Clin Pharmacol Ther; 2021 Jun; 109(6):1538-1545. PubMed ID: 33124053
[TBL] [Abstract] [Full Text] [Related]
12. FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia.
Yu SL; Zhang H; Ho BC; Yu CH; Chang CC; Hsu YC; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Pui CH; Yang JJ; Zhang J; Lin DT; Lin SW; Ma X; Yang YL
Sci Rep; 2020 Jul; 10(1):12074. PubMed ID: 32694622
[TBL] [Abstract] [Full Text] [Related]
13. Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions.
Dong Z; Cheng WA; Smith DL; Huang B; Zhang T; Chang WC; Wang X; Forman SJ; Kwak LW; Qin H
Cancer Immunol Immunother; 2020 Oct; 69(10):2139-2145. PubMed ID: 32451682
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics.
Pavlovic S; Kotur N; Stankovic B; Gasic V; Lucafo M; Decorti G; Zukic B
Curr Drug Metab; 2020; 21(1):53-62. PubMed ID: 32124692
[TBL] [Abstract] [Full Text] [Related]
15. Subclonal nt5c2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia.
Barz MJ; Hof J; Groeneveld-Krentz S; Loh JW; Szymansky A; Astrahantseff K; von Stackelberg A; Khiabanian H; Ferrando AA; Eckert C; Kirschner-Schwabe R
Blood; 2020 Mar; 135(12):921-933. PubMed ID: 31971569
[TBL] [Abstract] [Full Text] [Related]
16. FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.
Perelló-Reus CM; Català A; Caviedes-Cárdenas L; Vega-García N; Camós M; Pérez-Torras S; Pastor-Anglada M
Pharmacol Res; 2020 Jan; 151():104556. PubMed ID: 31778791
[TBL] [Abstract] [Full Text] [Related]
17. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
[TBL] [Abstract] [Full Text] [Related]
18. Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation.
Prockop S; Doubrovina E; Suser S; Heller G; Barker J; Dahi P; Perales MA; Papadopoulos E; Sauter C; Castro-Malaspina H; Boulad F; Curran KJ; Giralt S; Gyurkocza B; Hsu KC; Jakubowski A; Hanash AM; Kernan NA; Kobos R; Koehne G; Landau H; Ponce D; Spitzer B; Young JW; Behr G; Dunphy M; Haque S; Teruya-Feldstein J; Arcila M; Moung C; Hsu S; Hasan A; O'Reilly RJ
J Clin Invest; 2020 Feb; 130(2):733-747. PubMed ID: 31689242
[TBL] [Abstract] [Full Text] [Related]
19. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.
Hoell JI; Ginzel S; Kuhlen M; Kloetgen A; Gombert M; Fischer U; Hein D; Demir S; Stanulla M; Schrappe M; Zur Stadt U; Bader P; Babor F; Schuster F; Strahm B; Alten J; Moericke A; Escherich G; von Stackelberg A; Thiele R; McHardy AC; Peters C; Bornhauser B; Bourquin JP; Krause S; Enczmann J; Meyer LH; Eckert C; Borkhardt A; Meisel R
Blood Adv; 2019 Oct; 3(20):3143-3156. PubMed ID: 31648313
[TBL] [Abstract] [Full Text] [Related]
20. Mechanisms of
Moriyama T; Liu S; Li J; Meyer J; Zhao X; Yang W; Shao Y; Heath R; Hnízda A; Carroll WL; Yang JJ
Mol Cancer Ther; 2019 Oct; 18(10):1887-1895. PubMed ID: 31358663
[TBL] [Abstract] [Full Text] [Related]
[Next]
